Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Accounts Payables (2022 - 2025)

Historic Accounts Payables for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • Gossamer Bio's Accounts Payables fell 6349.36% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 6349.36%. This contributed to the annual value of $2.3 million for FY2024, which is 5803.47% down from last year.
  • As of Q3 2025, Gossamer Bio's Accounts Payables stood at $1.1 million, which was down 6349.36% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Accounts Payables registered a high of $5.5 million during Q4 2023, and its lowest value of $363000.0 during Q3 2022.
  • For the 4-year period, Gossamer Bio's Accounts Payables averaged around $2.2 million, with its median value being $2.2 million (2023).
  • In the last 5 years, Gossamer Bio's Accounts Payables skyrocketed by 36131.76% in 2023 and then crashed by 6349.36% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Accounts Payables stood at $1.5 million in 2022, then skyrocketed by 278.75% to $5.5 million in 2023, then tumbled by 58.03% to $2.3 million in 2024, then plummeted by 51.88% to $1.1 million in 2025.
  • Its Accounts Payables was $1.1 million in Q3 2025, compared to $1.9 million in Q2 2025 and $3.4 million in Q1 2025.